Breast Cancer And Current Treatment

Interferon-B

It is a type of cancer which happens in the cells of the breasts. It is one of the common types of cancer which is detected in female. It can happen in both male and female but is more common in female than in men. There has been huge support for breast cancer awareness and research has been done to help create new ways for analysis and cure of breast cancer. The survival rate for breast cancer patients has increased and the figure of deaths has gone down considerably. The major reasons have been mostly due to early detection and a new approach to treatment.

There are various forms of this disease. The triple negative breast cancer is the most aggressive form of this disease and the outcomes are often very poor. As of now this current form of cancer is resilient to available treatments. Scientists have been looking at different options and they believe that an existing form of antimicrobial therapy can help fight with this form of breast cancer.

The breast cancer is the 2nd most usually diagnosed kind of cancer in the US. The triple negative breast cancer accounts for roughly 15 percent of the breast cancer cases. This form of breast cancer is resistant to the most common type of therapy the chemotherapy. This is mostly due to the stem-like cancer cells. They promote the formation of new tumors in the body which does not help. Further new studies have found that the triple negative breast cancer cells may respond to other existing therapy used for multiple sclerosis called interferon-B. It was found that the interferon B improved the patient survival percentage following the chemotherapy. This is a cytokine and is a protein which is involved in cell signaling. It also has an antimicrobial effect and a complex immune regulatory impact. This is the major reason why it is used in the treatment of autoimmune diseases. The interferon B also acts on the stem-like properties of the breast cancer cells. It impairs the ability of the breast cancer cells to migrate and also prevents the formation of a metastatic tumor. The majority of the tumor cells are destroyed by chemotherapy but it is unable to remove the cancer stem cells. This is the major reason why the therapy fails in the patients. The interferon B can suppress the cells activity which can lead to improvement in the treatment outcomes.

In a study, the group noted that the interferon B targetted the cells directly. The cytokine had an effect on the cancer tissue even after the exposure has ceased. Also, the migration cells halved when compared to the control tissues that were not exposed to the treatment.

The cells that were treated with the interferon B had a reduced tendency to tumor-sphere formation compared to those which were not. With the recent finding and advances in medical technology, the chances for an effective and curable treatment has improved.